Gynecology.
D000028:Abortion, Induced / Q000009:adverse effects*; D000230:Adenocarcinoma / Q000473:pathology*; D001778:Blood Coagulation Disorders / Q000139:chemically induced; D002278:Carcinoma in Situ / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D003475:Curettage; D004106:Dilatation; D004622:Embryo, Mammalian / Q000473:pathology; D005260:Female; D005333:Fetus / Q000473:pathology; D005865:Gestational Age; D006801:Humans; D006955:Hypernatremia / Q000139:chemically induced; D006982:Hypertonic Solutions; D008207:Lymphatic Metastasis; D010121:Oxytocin / Q000627:therapeutic use; D011247:Pregnancy; D011379:Prognosis; D013925:Thromboplastin / Q000502:physiology; D014481:United States; D002583:Uterine Cervical Neoplasms / Q000473:pathology*; D014594:Uterine Neoplasms / Q000473:pathology*; D014626:Vaginal Smears
D006982:Hypertonic Solutions; D010121:Oxytocin; D013925:Thromboplastin